SciSparc Ltd. (NASDAQ:SPRC) Short Interest Up 207.1% in April

SciSparc Ltd. (NASDAQ:SPRC) saw a large increase in short interest in April. As of April 15th, there was short interest totalling 523,900 shares, an increase of 207.1% from the March 31st total of 170,600 shares. Based on an average daily volume of 1,290,000 shares, the days-to-cover ratio is currently 0.4 days. Approximately 21.4% of the shares of the stock are sold short.

SciSparc Trading Up 4.8 %

SciSparc stock traded up $0.06 during trading hours on Friday, reaching $1.32. 192,438 shares of the stock were exchanged, compared to its average volume of 868,613. SciSparc has a twelve month low of $1.15 and a twelve month high of $23.66. The stock has a 50 day moving average of $2.42 and a two-hundred day moving average of $4.18.

SciSparc Company Profile

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.